Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization

Area of Science:

• Molecular Oncology
• Genomics
• Prostate Cancer Research

Background:

• Field cancerization describes aberrant cells in tumor-adjacent histologically normal tissues (TAHN).
• Understanding these molecular changes in TAHN is crucial for early cancer detection and intervention.

Purpose of the Study:

• To characterize field cancerization in prostate cancer by analyzing gene expression in TAHN.
• To identify novel molecular markers in TAHN that are indicative of pre-malignant changes.

Main Methods:

• RNA extracted from paired patient tumor and TAHN tissues (1 cm from margin) and normal prostate tissues.
• Microarray expression analysis was performed.
• Quantitative reverse transcriptase PCR (qRT-PCR) used for validation of key transcripts.

Main Results:

• Eleven novel transcripts were significantly up-regulated in TAHN and tumor tissues compared to normal tissues.
• Specific genes (e.g., EGR1, TTP, Testican, FAS) showed mutually up-regulated expression in both tumors and TAHN.
• Expression patterns were confirmed in an independent validation set.

Conclusions:

• Demonstrated expressional changes in field-cancerized prostatic TAHN at defined distances from tumor margins.
• Identified potential early diagnostic indicators for prostate cancer biopsies.
• Highlighted potential targets for chemo-preventive intervention in pre-malignant prostate disease.